U.S. Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture, Others), By End-use (Hospitals, POCT, Laboratories), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Test type
                        1.1.2. End use
                        1.1.3. Country scope
                        1.1.4. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Test type outlook
                        2.2.2. End use outlook
                        2.2.3. Country outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Influenza Diagnostics Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Market Dynamics
                        3.3.1. Market driver analysis
                        3.3.2. Market restraint analysis
                    3.4. U.S. Influenza Diagnostics Market Analysis Tools
                        3.4.1. Industry Analysis - Porter’s Five Forces
                            3.4.1.1. Supplier power
                            3.4.1.2. Buyer power
                            3.4.1.3. Substitution threat
                            3.4.1.4. Threat of new entrant
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Technological landscape
                            3.4.2.3. Economic landscape
Chapter 4. U.S. Influenza Diagnostics Market: Test Type Estimates & Trend Analysis
                    4.1. U.S. Influenza Diagnostics Market: Key Takeaways
                    4.2. U.S. Influenza Diagnostics Market: Test Type Movement & Market Share Analysis, 2022 & 2030
                    4.3. RIDT
                        4.3.1. RIDT market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.4. RT-PCR
                        4.4.1. RT-PCR market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.5. Cell Culture
                        4.5.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.6. Others
                        4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. U.S. Influenza Diagnostics Market: End-use Estimates & Trend Analysis
                    5.1. U.S. Influenza Diagnostics Market: Key Takeaways
                    5.2. U.S. Influenza Diagnostics Market: End-use Movement & Market Share Analysis, 2022 & 2030
                    5.3. Hospitals
                        5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.4. POCT
                        5.4.1. POCT market estimates and forecasts, 2018 to 2030 (USD Million)
                    5.5. Laboratories
                        5.5.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. U.S. Influenza Diagnostics Market: Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Market Participant Categorization
                        6.2.1. 3M
                            6.2.1.1. Company overview
                            6.2.1.2. Financial performance
                            6.2.1.3. Product benchmarking
                            6.2.1.4. Strategic initiatives
                        6.2.2. Abbott
                            6.2.2.1. Company overview
                            6.2.2.2. Financial performance
                            6.2.2.3. Product benchmarking
                            6.2.2.4. Strategic initiatives
                        6.2.3. BD
                            6.2.3.1. Company overview
                            6.2.3.2. Financial performance
                            6.2.3.3. Product benchmarking
                            6.2.3.4. Strategic initiatives
                        6.2.4. Meridian Bioscience
                            6.2.4.1. Company overview
                            6.2.4.2. Financial performance
                            6.2.4.3. Product benchmarking
                            6.2.4.4. Strategic initiatives
                        6.2.5. Quidel Corporation
                            6.2.5.1. Company overview
                            6.2.5.2. Financial performance
                            6.2.5.3. Product benchmarking
                            6.2.5.4. Strategic initiatives
                        6.2.6. F. Hoffmann-La Roche Ltd
                            6.2.6.1. Company overview
                            6.2.6.2. Financial performance
                            6.2.6.3. Product benchmarking
                            6.2.6.4. Strategic initiatives
                        6.2.7. SA Scientific Ltd.
                            6.2.7.1. Company overview
                            6.2.7.2. Financial performance
                            6.2.7.3. Product benchmarking
                            6.2.7.4. Strategic initiatives
                        6.2.8. SEKISUI Diagnostics
                            6.2.8.1. Company overview
                            6.2.8.2. Financial performance
                            6.2.8.3. Product benchmarking
                            6.2.8.4. Strategic initiatives
                        6.2.9. Thermo Fisher Scientific Inc.
                            6.2.9.1. Company overview
                            6.2.9.2. Financial performance
                            6.2.9.3. Product benchmarking
                            6.2.9.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 U.S. influenza diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 3 U.S. influenza diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. influenza diagnostics: Market outlook
Fig. 9 U.S. influenza diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. influenza diagnostics market driver impact
Fig. 14 U.S. influenza diagnostics market restraint impact
Fig. 15 U.S. influenza diagnostics market strategic initiatives analysis
Fig. 16 U.S. influenza diagnostics market: Test type movement analysis
Fig. 17 U.S. influenza diagnostics market: Test type outlook and key takeaways
Fig. 18 RIDT market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 RT-PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 U.S. influenza diagnostics market: End use movement analysis
Fig. 23 U.S. influenza diagnostics market: End use outlook and key takeaways
Fig. 24 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 POCT market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)